Karen Reitsma joins the management team of Rexgenero


London, UK. Rexgenero Ltd appoints Karen Reitsma as Vice President, Clinical and Regulatory Development. Karen is an expert in the clinical development of cell therapies in Europe and the United States and brings extensive experience in complex cell therapies.  Karen has previously held senior roles in clinical development at HAL Allergy, Kiadis, INC Research, Merck Serono and in academic research.

innovative cell therapies
Contact us